Recent Articles

• 
  Biotech

  Quantum Computing May Hold Answers to Tough Diseases

  On the 12th at Yonsei University’s Sinchon Campus in Seoul, Professor Hansik Han of Yonsei University’s Department of Quantum Information Science (Director of the AI Research Center at the Milner Therapeutics Institute, University of Cambridge, UK). Photo by Byunggu Lee, Dong-A Science reporter 2bot

  2026.03.30
• 
  Clinical Trial

  GC Biopharma Begins Phase 3 Varicella Vaccine Trials in Vietnam

  Panoramic view of GC Green Cross headquarters. Provided by GC Green Cross GC Green Cross announced on the 27th that it has received approval from the Vietnam Ministry of Health for a Phase 3 clinical trial plan (IND) for the two-dose varicella vaccine “Varicella Vaccine Live (Varicella)” (2-dose sch

  2026.03.27
• 
  Pharmaceutical R&D

  New Paradigm in Hair Loss Care: OND-1 Regeneration Drug Development Begins

  The history of the bioindustry is essentially the history of how precisely the invisible principles of life are understood and how accurately they are translated into treatment. At every turning point, one question has always existed.“Where, how, and how precisely must a drug reach its target?” The

  2026.03.27
• 
  Global Expansion

  SK Biopharm Begins Cenobamate Prescriptions in China

  SK Biopharmaceuticals announced on the 26th that prescriptions for its new anti-epileptic drug cenobamate (product name Xcopri, etc.) have begun at major hub hospitals in China under the name Yifurui (翼弗瑞).The product has been officially launched less than three months after early approval as a new

  2026.03.26
• 
  Medical / Clinical Case

  Daewoong UDCA Proves Long-Term Gallstone Prevention After Gastric Surgery

  Daewoong Pharmaceutical headquarters Ursodeoxycholic acid (UDCA), the main ingredient of Daewoong Pharmaceutical’s liver function improver “Ursosa,” has been shown to reduce the risk of gallstones after gastric cancer surgery. Clinical results indicated that, even when UDCA is taken for 12 months af

  2026.03.26
• 
  AI Healthcare

  Alfee Launches AI ECG Tool for Health Checkups

  Photo courtesy of Alfee Alfee Co., Ltd. (CEO Kim Joong-hee, hereafter “Alfee”) announced that it has officially launched ECG Buddy Clinic, an artificial intelligence-based electrocardiogram (ECG) analysis solution specialized for health screening settings, and will participate for the first time in

  2026.03.25
• 
  Medical / Drug Development

  New Material Uses Korean Herbs to Protect Prostate Health

  ‘Chamdanggui-Astragalus Extract Complex (SHPro)’ is a functional ingredient for prostate health formulated by blending 100% domestically produced Chamdanggui (Korean Angelica gigas) and Astragalus at an optimal ratio. When the complex was administered for 12 weeks to 84 men with benign prostatic hyp

  2026.03.25
• 
  Medical / Research

  HER2-Positive, Triple-Negative Breast Cancer: Brain MRI Essential

  Some breast cancer patients may require regular brain magnetic resonance imaging (MRI) scans because brain metastasis may have already occurred even in the absence of any symptoms, according to new research findings. In particular, the study confirmed that brain metastases can be detected at an earl

  2026.03.25
• 
  AI Healthcare

  Moving Walls, AI-Generated Charts Bring ‘Future Hospital’ to Life

  Since the 9th, “HIMSS (Healthcare Information and Management Systems Society) 2026” held in Las Vegas, USA, has drawn about 25,000 participants, achieving great success. There were about 1,100 registered company booths. Las Vegas = Medical Specialist Reporter and Physician Jinhan Lee likeday@donga.c

  2026.03.25
• 
  Global Expansion

  Celltrion Ramps Up Global Plant Investment to Boost Profit

  Celltrion’s Branchburg plant in the U.S. Celltrion will invest more than KRW 1 trillion to expand its production facilities in response to surging demand for biopharmaceuticals.Celltrion announced on the 24th that it will expand its drug substance (DS) production capacity at home and abroad to a tot

  2026.03.24